Harnessing cells to improve transport of nanomedicines
-
Published:2024-10
Issue:
Volume:203
Page:114446
-
ISSN:0939-6411
-
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
-
language:en
-
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics
Author:
Bezze Andrea,
Mattioda Carlotta,
Ciardelli Gianluca,
Mattu ClaraORCID
Reference260 articles.
1. World Cancer Report 2020;Wild;Int. Agency. Res. Cancer,2020
2. Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials;Lin;Sci. Transl. Med,2019
3. B.A. Chabner, T.G. Roberts, Chemotherapy and the war on cancer, Nat. Rev. Cancer, vol. 5, Preprint at 10.1038/nrc1529 (2005).
4. Y. Dang, J. Guan, Nanoparticle-based drug delivery systems for cancer therapy, Smart Mater. Med., vol. 1 Preprint at 10.1016/j.smaim.2020.04.001 (2020).
5. Mechanisms of Multidrug Resistance in Cancer Chemotherapy;Bukowski;Int. J. Mol. Sci,2020